Spots Global Cancer Trial Database for Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients
Official Title: Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients: A Randomized Multicenter Clinical Trial
Study ID: NCT01949974
Conditions
Study Description
Brief Summary: The purpose of this clinical trial is to compare a non-pharmaceutical intervention (Integral Attention Program or PAI) versus standard palliative chemotherapy treatment plus PAI in patients with advanced cancer who have already received at least a first course of chemotherapy but had proven therapeutic failure. The study hypothesis is that palliative chemotherapy offers no clear benefits in relation to quality-of-life-adjusted survival compared to a comprehensive care program.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospital General de l'Hospitalet de Llobregat, Hospitalet de Llobregat, Barcelona, Spain
Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain
Contact Details
Name: Antonio Pascual, Dr., PhD
Affiliation: Palliative Unit. Clinical Oncology Service. Hospital de la Santa Creu i Sant Pau. Barcelona. Spain.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
